Prevalence of Genomic Alterations in EGFR, KRAS, NRAS, and BRAF Among Early-Stage Nonsquamous Non–Small Cell Lung Cancer in Brazil Among 273 patients, cCRT and sCRT were administered with equal ...

Time burden and healthcare costs associated with docetaxel in patients with metastatic castration-sensitive prostate cancer (mCSPC) initiating an androgen receptor pathway inhibitor (ARPI) –based ...

Injectable GLP-1 receptor agonists show reduced effectiveness in real-world settings due to early discontinuation and low maintenance dosing. Patients maintaining treatment lost more weight, with high ...

New research shows patients commonly take lower doses of nintedanib, and the majority are also taking immunomodulatory drugs. Real-world data on usage of the tyrosine kinase inhibitor nintedanib (Ofev ...

Pharma and biotech companies have access to an unprecedented variety of health data, from electronic health records and medical or pharmacy claims to genomic, behavioral and sensor data. Yet it can be ...

Angela Jia, MD, PhD, is a radiation oncologist specializing in stereotactic body radiation therapy (SBRT), adaptive radiotherapy, and clinical trials focused on prostate, bladder, and kidney cancers.